EAST.H — EastWest Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00Consumer CyclicalsHighly SpeculativeMicro Cap
Annual cashflow statement for EastWest Bioscience, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -1.13 | -1.63 |
| Depreciation | ||
| Non-Cash Items | -0.316 | 0.106 |
| Unusual Items | ||
| Equity in Net Earnings/Losses | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 0.997 | 0.715 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Net Change in Other Assets & Liabilities | ||
| Cash from Operating Activities | -0.324 | -0.688 |
| Capital Expenditures | -0.001 | -0.009 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | 0.068 | 0.03 |
| Sale of Fixed Assets | ||
| Purchase of Investments | ||
| Cash from Investing Activities | 0.067 | 0.021 |
| Financing Cash Flow Items | 0.087 | 1.28 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 0.31 | 1.62 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0.052 | 0.949 |